Thalidomide Survivors Contribution Program Class Proceeding – September 3, 2024 & September 11, 2024
September 3, 2024
CORRECTED
We were advised by the Attorney General for Canada that the Government of Canada’s Office of Audit and Evaluation (OAE) at Health Canada will be conducting an evaluation of the Canadian Thalidomide Survivors Support Program (CTSSP) for the period from April 2019 to March 2024.
We were advised that the OAE may be contacting confirmed Thalidomide Survivors pursuant to the CTSSP to conduct interviews. We were advised that the interviews are voluntary and confidential.
We have been advised to expect such evaluation to take place after September 1, 2024.
